Clinical Trial Update: SGLT2 Inhibitors in Treating Patients With PCOS [NA]

View source ↗

Summary

A completed clinical trial in China is evaluating the use of SGLT2 inhibitors to treat Polycystic Ovary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Polycystic Ovary Syndrome | NA | Status: COMPLETED